Related Experiment Video
Updated: Jun 23, 2025

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies
Published on: June 20, 2015
An Analysis of Clinical Outcomes of Exploratory Pediatric Metformin Ingestions Reported to the Texas Poison Center
Shawn M Varney1, Sarah Watkins2, Haylea Stuteville3
1University of Texas Health San Antonio - San Antonio, TX, USA.
Insights
Pediatric metformin ingestions under 85 mg/kg generally result in uneventful medical outcomes. This study analyzed 669 cases in children 5 years and younger, finding no major effects or deaths.
Area of Science:
- Pediatric Toxicology
- Clinical Pharmacology
- Emergency Medicine
Background:
- Poison control centers establish triage guidelines for pediatric metformin ingestions.
- The established network guideline is 1700 mg, or 85 mg/kg.
Purpose of the Study:
- To investigate the dose, clinical course, and outcomes of inadvertent metformin ingestions in young children.
- To analyze data from a statewide poison center network for patients 5 years old and younger.
Main Methods:
- Retrospective review of a poison center database from 2011 to 2021.
- Inclusion criteria: metformin ingestions in patients 5 years and younger.
- Descriptive statistics were used to analyze variables including age, weight, dose, symptoms, and outcomes.
Main Results:
- A total of 669 cases were analyzed; most ingestions (98.5%) were unintentional.
- Median recorded dose was 500 mg (42.4 mg/kg) in 15.4% of cases with available data.
- Most patients (66.5%) were managed non-healthcare facilities; among those seeking care, 82.8% were discharged from the emergency department, with no major effects or deaths reported.
Conclusions:
- Pediatric metformin ingestions, particularly those under 85 mg/kg, are associated with predominantly benign medical outcomes.
- Limited recorded dosage information in pediatric ingestions presents a challenge for precise risk assessment.
- The findings support the current triage guidelines for pediatric metformin exposures.
Abstract:
Background: Poison centers develop triage threshold guidelines for pediatric metformin ingestions. Our network uses 1700 mg, or 85 mg/kg. Objective: To describe the dose, clinical course, and outcomes for inadvertent metformin ingestions in children 5 years old and younger reported to our statewide poison center network. Methods: We searched the poison center database 2011 to 2021 for metformin ingestions in patients 5 years and younger. Variables included age, sex, weight, dose, symptoms, outcome, and more. We used descriptive statistics with medians and interquartile ranges (IQR) for continuous variables. Results: Of 669 cases, exposures by age were 208 (31.1%) 1 to 2 years, and 275 (41.1%) 2 years. Weight was recorded in 342 (51.1%) (median 13.5 kg; IQR: 3.7 kg), and dose in 149 (22.3%) (median 500 mg; IQR: 500 mg). Milligram/kilogram values were available for 103 (15.4%) with median 42.4 mg/kg, IQR: 39 mg/kg. Most (647, 98.5%) exposures were unintentional. Most (445/669, 66.5%) were managed at a non-healthcare facility, while 204 (30.7%) were already at or referred to a healthcare facility. Of these 204 patients, 169 (82.8%) were evaluated and treated at the emergency department and discharged. Four (2%) were admitted to critical care, and 7 (3.4%) to the ward. Medical outcomes by effect were 5 (0.7%) minor, 2 (0.3%) moderate, 253 (37.8%) none, 292 (43.6%) not followed (minimal effects possible), and no major effects or deaths. Of 20 clinical occurrences reported, vomiting was most common (8, 1.2%). Conclusion: Despite little recorded dosage information, pediatric metformin ingestions under 85 mg/kg had predominantly uneventful medical outcomes.
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Regulation
Factors Affecting Drug Response: Overview

